Leukemia Clinical Trials in Philadelphia

Showing 1081-1100 of 1,502 trials

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

NCT01929408

The purpose of this study is to compare treatment methods and outcomes of patients diagnosed with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)

Fred Hutchinson Cancer Center703 participantsStarted Jul 2013

Stanford, California, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +9 more locations

COMPLETEDPhase 3< 1 mile

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

NCT00547651

This study drug (Amrubicin) is believed to work by stopping the tumor cells in your body from growing. The purpose of this study is to evaluate the effect of amrubicin compared to topotecan in the treatment of small cell lung cancer.

Small Cell Lung Cancer

Celgene637 participantsStarted Sep 2007

Muscle Shoals, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +137 more locations

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

Leukemia Trials in Other Cities

Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants

A Study LY2228820 for Recurrent Ovarian Cancer

A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

A Study in Non-Small Cell Lung Cancer

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia

The Small Intestine Bacterial Overgrowth Study Pilot

Study of Ramucirumab in Ovarian Cancer

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications

A Study of Advanced or Metastatic Non-small Cell Lung Cancer

A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

Other Conditions in Philadelphia